MoneyWorks4Me

Piramal Pharma informs about disclosure

01 Jun 2023 Evaluate

Piramal Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Caisse De Depot Et Placement Du Quebec.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1847.20
Dr. Reddys Labs. 1222.45
Cipla 1394.10
Lupin 2071.65
Zydus Lifesciences 1213.15
View more..